Liquid Biopsy Components in Neurological Diseases
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (30 January 2024) | Viewed by 6981
Special Issue Editor
Interests: neurological diseases with main focus on multiple sclerosis; liquid biopsy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
During the last decade, liquid biopsy is gaining attention in an area of neurological diseases. The liquid biopsy is performed by extracting and analysis of non-solid biological tissues, i.e. serum, plasma, tear, and saliva, without the need to undergo the invasive procedure. A liquid biopsy can be used for screening several components such as extracellular vesicles (EVs) (exosomes, microvesicles, and apoptotic bodies), cell-free DNA (cfDNA), microRNA (miRNA), transfer RNA (t-RNA), circulating tumor DNA (ct-RNA), circulating tumor cells (CTCs) derived from body fluids. Recent advancements in this field, including the use of new technologies, the development and standardization of new methods, have helped to overcome some of the technical issues related with liquid biopsy. This edition’s primary focus is to address key questions regarding role of different liquid components, and the identification of potential biomarkers and therapeutic targets in complex neurological conditions including Alzheimer’s disease, amyotrophic lateral sclerosis, CNS tumors, epilepsy, multiple sclerosis, neuroinfectious disease and Parkinson’s disease.
Dr. Sunny Malhotra Sareen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liquid biopsy
- microRNA
- exosomes
- cfDNA
- neurological diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
